^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
BRCAaccuTest PLUS

Company:
NGeneBio
Type:
CE Marked
Related tests:

Details

Evidence
BRCAaccuTest PLUS is a medical device certified by FDA Thailand and can be used not only as a diagnostic test for breast cancer target treatment but also as a test for mutation screening of BRCA1/2 genes.
Cancer:
Breast Cancer, Ovarian Cancer
Gene:
BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset)
Method:
Next-Generation Sequencing (NGS)